Foresite Capital Management Vi Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$460.3M
Q ending 2026-03-31
Prior quarter
$330.8M
Q ending 2025-12-31
Change
+39.1% QoQ · +152.1% YoY
Positions
17
reported holdings
Largest positions
All 17 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Cg Oncology, Inc. | CGON | Shares | $150.3M | 2.2M |
| Alumis Inc. | ALMS | Shares | $93.6M | 4.2M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $54.2M | 1.4M |
| Corvus Pharmaceuticals, Inc. | CRVS | Shares | $26.8M | 1.8M |
| Denali Therapeutics Inc. | DNLI | Shares | $23.2M | 1.2M |
| Agios Pharmaceuticals, Inc. | AGIO | Shares | $17.8M | 525K |
| Verastem, Inc. | VSTM | Shares | $16.7M | 3.1M |
| Kymera Therapeutics, Inc. | KYMR | Shares | $12.2M | 146K |
| Minerva Neurosciences, Inc. | NERV | Shares | $12.0M | 2.0M |
| Celldex Therapeutics, Inc. | CLDX | Shares | $10.0M | 316K |
| Ataibeckley Inc. | ATAI | Shares | $9.7M | 2.8M |
| Hinge Health, Inc. | HNGE | Shares | $8.5M | 220K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Shares | $7.7M | 212K |
| Onkure Therapeutics, Inc. | OKUR | Shares | $6.0M | 1.4M |
| Jade Biosciences, Inc. | JBIO | Shares | $4.5M | 320K |
| Gh Research Plc | Shares | $4.4M | 315K | |
| Zura Bio Ltd | Shares | $2.7M | 450K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.